Abstract
Full text available
CNS & Neurological Disorders - Drug Targets
Title:Nanotechnology and Drug Delivery: Getting There is Only Half of the Challenge! (Commentary)
Volume: 11 Issue: 1
Author(s): Russell J. Andrews
Affiliation:
Abstract: Full text available
Export Options
About this article
Cite this article as:
J. Andrews Russell, Nanotechnology and Drug Delivery: Getting There is Only Half of the Challenge! (Commentary), CNS & Neurological Disorders - Drug Targets 2012; 11 (1) . https://dx.doi.org/10.2174/187152712799960754
DOI https://dx.doi.org/10.2174/187152712799960754 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Sulfonamides and Sulfonylated Derivatives as Anticancer Agents
Current Cancer Drug Targets The Clinical Difference between Gabapentin and Pregabalin: Data from a Pilot Comparative Trial
Reviews on Recent Clinical Trials The AMPAR Antagonist Perampanel Regulates Neuronal Necroptosis via Akt/GSK3β Signaling After Acute Traumatic Injury in Cortical Neurons
CNS & Neurological Disorders - Drug Targets Towards a Causal Model for Disgust in the Anxiety Disorders: An Integration of Evidence from Neuroscience
Current Psychiatry Reviews Preface
Current Pharmaceutical Design From Anreps Phenomenon to Myocardial Hypertrophy: Role of the Na+/H+ Exchanger
Current Cardiology Reviews Microemulsions as Carriers for Therapeutic Molecules
Recent Patents on Drug Delivery & Formulation The Effects of Obesity on Drug Metabolism in Children
Drug Metabolism Letters Curcumin: Not So Spicy After All
Mini-Reviews in Medicinal Chemistry Targeting Kinin Receptors for the Treatment of Neurological Diseases
Current Pharmaceutical Design The Structure and Functions of P-Glycoprotein
Current Medicinal Chemistry Patent Selections
Recent Patents on DNA & Gene Sequences Review of Medicinal Plants Common to Traditional Chinese and Indian Medicines with Relevance to Non-Communicable Diseases
Current Traditional Medicine MCI Patients Declining and Not-Declining at Mid-Term Follow-Up: FDG-PET Findings
Current Alzheimer Research Fibromyalgia: The Prototypical Central Sensitivity Syndrome
Current Rheumatology Reviews Emerging Use of Nanotechnology in the Treatment of Neurological Disorders
Current Pharmaceutical Design Levofloxacin-Induced Delirium in a Patient Suffering from Schizoaffective Disorder and Multiple Sclerosis
Current Drug Safety Interleukin-1β Plays a Role in the Activation of Peripheral Leukocytes after Blood-Brain Barrier Rupture in the Course of Subarachnoid Hemorrhage
Current Neurovascular Research Childhood Infectious Encephalitis: An Overview of Clinical Features, Investigations, Treatment, and Recent Patents
Recent Patents on Inflammation & Allergy Drug Discovery Ontologies of Drug Discovery and Design for Neurology, Cardiology and Oncology
Current Pharmaceutical Design